Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (17820)	1/16/1999 5:37:00 AM
From: DaiS	Read Replies (1) \| Respond to of 23519

MK, The ICOS pill is either more or less effective inhibitor of PDE5 than sildenafil. If more effective then probably less safe and vice-versa. It might be more specific for PDE5 than PDE6 this would reduce visions side effects. I would like if someone could point me to some hard data about ICOS pill, is there any, or do we have just analyst bs. I recall Pfizer said themselves that they were working on wafer, 2 or more years away. I am curious as to how these independent workers get the sildenafil. Do they crunch up and dissolve the blue pills? Wafer would be OK. Nasal spray? Not like a pill, more like a local solution at wrong end of body. I am not convinced Pfizer could sell it in a dignified manner, their supporters having turned up their noses at muse and Vivus. As regards gene therapy, a local treatment, that might make pills obsolete......I am hoping we might here something soon from Vivus. I suspect however that the scientists have some influence here and prefer announcement when phase I trial approval. DaiS